Interventional treatment for progressive hepatic metastases from gastric cancer after chemotherapy: a retrospective analysis of 72 cases

刘鹏,朱旭,杨仁杰,陈辉,徐海峰,高嵩,朱林忠,王晓东

DOI: https://doi.org/10.3969/j.issn.1008-794X.2013.09.010

2013-01-01

Abstract:Objective: To evaluate the efficacy and safety of hepatic arterial infusion chemotherapy in treating progressive liver metastases from gastric cancer, and to retrospectively analyze the relationship between the interventional treatment and the prognosis. Methods: During the period from June 2006 to August 2011, a total of 72 patients with progressive hepatic metastases from gastric cancer after systemic chemotherapy were admitted to authors' hospital. The clinical data, including the interventional managements, the arterial chemoperfusion scheme, etc., were retrospectively analyzed. For the quantitative data variance analysis was used, while for the qualitative data chi-squared test was adopted. Kaplan-Meier method was employed to estimate the survival rate, and Log-rank test was used to compare the survival rates, which was brought into Cox regression model for multi-factor analysis. Results: After interventional treatment, the median progress-free survival time was 5.0 months and the median survival time was 8.0 months with an overall respond rate of 40.3% (29/72) and a disease-control rate of 77.8% (56/72). The factors related to the therapeutic results included the blood supply of tumor, tumor staining, use of OXA chemotherapy scheme, etc. When the same therapeutic scheme was employed, the interventional management for the patients with progressive hepatic metastases from gastric cancer after systemic chemotherapy still could get satisfactory results: CR in one case (3.8%, 1/26), PR in 12 cases (46.2%, 12/26) and SD in 9 cases (34.6%, 9/26) with no obvious adverse effects. Conclusion: For the treatment of liver metastases from gastric cancer, interventional management is safe and effective, although standard intervention scheme is needed to be further studied in order to perfect its clinical application.